Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor α chain-knockout mice infected with Angiostrongylus cantonensis

Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Angel F. López, Colin J. Sanderson, Jennifer R. Gamble et al. · The Journal of Experimental Medicine · 1988 · 959 citations · Full text

Life Sciences, Immunology, Pathobiology +13

Antibody to Interleukin-5 Inhibits Helminth-Induced Eosinophilia in Mice

Robert L. Coffman, Brian W. P. Seymour, S Hudak et al. · Science · 1989 · 630 citations

Veterinary Medicine, Immunology, Pathology +17

IL-5-Deficient Mice Have a Developmental Defect in CD5+ B-1 Cells and Lack Eosinophilia but Have Normal Antibody and Cytotoxic T Cell Responses

Manfred Köpf, Frank Brombacher, Philip D. Hodgkin et al. · Immunity · 1996 · 603 citations · Full text

Life Sciences, Developmental Biology, Immunology +17

IgA-induced eosinophil degranulation.

R I Abu-Ghazaleh, Takao Fujisawa, J Mĕstecký et al. · The Journal of Immunology · 1989 · 387 citations · Full text

Life Sciences, Immunology, Physiology +12

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.

A Tominaga, N. Koyama, Shigeki Katoh et al. · The Journal of Experimental Medicine · 1991 · 297 citations · Full text

Life Sciences, Immunology, Pathology +15